Gasmi Mehdi

Avg. Two Year Performance

No purchase track record

19% Avg. Sale Return

9% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	13%	32%	43%	17%	19%
Sale Success Rate	7 of 8	6 of 8	5 of 8	3 of 8	3 of 8

Adverum Biotechnologies, Inc.

Drugs » Biotechnology

Director:

Holdings: 274.44K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--